Status:
COMPLETED
Treatment for Sleep Disturbance in Orthopaedic Trauma Patients
Lead Sponsor:
Stanford University
Conditions:
Sleep Disturbance
Trauma
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The purpose of the study is to test the efficacy of sleep treatment in human patients following traumatic injury. Specifically, the study will determine if treatment consisting of melatonin and educat...
Eligibility Criteria
Inclusion
- New patients visiting the Orthopaedic Trauma Clinic or undergoing orthopaedic surgery in Stanford Hospital following traumatic injury. Accidental traumatic fracture injuries that are operative and non-operative. Must be able to swallow tablets.
Exclusion
- Documented head trauma. Cognitive impairments. Minors. Previously diagnosed sleep disorders. Sleep apnea. Enrolled in another study. Women who are pregnant or may become pregnant or are nursing. Hypertension. Diabetes. Endocrine, autoimmune, depressive, bleeding or seizure disorders.
Key Trial Info
Start Date :
January 7 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 24 2021
Estimated Enrollment :
90 Patients enrolled
Trial Details
Trial ID
NCT03779243
Start Date
January 7 2019
End Date
August 24 2021
Last Update
December 3 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Stanford
Stanford, California, United States, 94305